MKS (NASDAQ:MKSI) Given New $380.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan raised its MKS price target to $380 from $365 and maintained an “Overweight” rating, implying 23.57% upside from the reported share price.
• MKS exceeded quarterly expectations, reporting $3.30 adjusted EPS versus $2.91 expected and $1.25 billion in revenue, up 28.3% year over year. Management guided for third-quarter EPS of $3.27–$3.89, while analysts maintain a consensus “Moderate Buy” rating with an average target of $384.64.
• Despite strong institutional ownership of 99.79% and improving AI-related demand, insiders sold 54,406 shares worth about $17.6 million over the past 90 days, representing a potential cautionary signal.

MKS (NASDAQ:MKSI - Get Free Report) had its target price upped by equities researchers at JPMorgan Chase & Co. from $365.00 to $380.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an "overweight" rating on the scientific and technical instruments company's stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 23.57% from the company's current price.

Several other research analysts have also issued reports on MKSI. TD Cowen restated a "buy" rating on shares of MKS in a report on Thursday, May 7th. Wells Fargo & Company upped their price objective on shares of MKS from $300.00 to $325.00 and gave the company an "equal weight" rating in a research note on Friday. Mizuho set a $360.00 price objective on shares of MKS in a research report on Thursday. Needham & Company LLC lifted their target price on shares of MKS from $360.00 to $390.00 and gave the stock a "buy" rating in a research note on Thursday. Finally, Bank of America upped their price target on shares of MKS from $380.00 to $500.00 and gave the company a "buy" rating in a research report on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, MKS has a consensus rating of "Moderate Buy" and an average price target of $384.64.

MKS Trading Up 5.6%

Shares of NASDAQ MKSI traded up $16.22 during trading on Friday, reaching $307.53. The company had a trading volume of 523,686 shares, compared to its average volume of 1,405,757. The stock has a market cap of $20.77 billion, a P/E ratio of 48.98, a PEG ratio of 0.84 and a beta of 1.98. The company's fifty day moving average price is $348.18 and its 200-day moving average price is $289.00. The company has a quick ratio of 0.70, a current ratio of 1.11 and a debt-to-equity ratio of 0.94. MKS has a 12 month low of $97.30 and a 12 month high of $447.62.

MKS (NASDAQ:MKSI - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.39. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.20 billion. MKS had a return on equity of 25.35% and a net margin of 10.15%.The firm's revenue was up 28.3% compared to the same quarter last year. During the same period last year, the company earned $1.77 earnings per share. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. As a group, research analysts expect that MKS will post 11.81 earnings per share for the current year.

Insiders Place Their Bets

In other MKS news, EVP David Philip Henry sold 2,500 shares of the company's stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total transaction of $826,250.00. Following the sale, the executive vice president directly owned 16,341 shares of the company's stock, valued at $5,400,700.50. This represents a 13.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP John Edward Williams sold 457 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $288.31, for a total transaction of $131,757.67. Following the transaction, the executive vice president owned 4,098 shares of the company's stock, valued at $1,181,494.38. This represents a 10.03% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 54,406 shares of company stock worth $17,577,866 in the last ninety days. 0.57% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On MKS

Several institutional investors have recently made changes to their positions in MKSI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of MKS by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company's stock valued at $21,434,000 after purchasing an additional 9,170 shares during the period. EverSource Wealth Advisors LLC boosted its stake in MKS by 63.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company's stock worth $83,000 after purchasing an additional 325 shares during the period. First Trust Advisors LP grew its holdings in MKS by 3,545.6% during the 2nd quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company's stock valued at $14,036,000 after buying an additional 137,392 shares in the last quarter. Cerity Partners LLC purchased a new position in MKS during the 2nd quarter valued at about $1,676,000. Finally, AXA S.A. increased its position in shares of MKS by 22.8% during the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company's stock valued at $2,907,000 after buying an additional 5,430 shares during the period. Hedge funds and other institutional investors own 99.79% of the company's stock.

Trending Headlines about MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Q2 results exceeded expectations: MKS reported adjusted EPS of $3.30 versus the $2.91 analyst consensus, while revenue reached $1.25 billion, up 28.3% year over year and ahead of the $1.20 billion estimate. MKSI Q2 Earnings Beat Estimates, Revenues Increase Year Over Year
• Positive Sentiment: Upbeat third-quarter outlook: Management guided for EPS of $3.27–$3.89 and revenue of $1.3–$1.4 billion, above consensus expectations of $3.17 EPS and $1.2 billion in revenue. The outlook suggests continued momentum across semiconductor and other end markets.
• Positive Sentiment: AI demand is improving visibility: On the earnings call, MKS said it is ramping semiconductor and advanced-packaging capacity to support AI-driven demand, with stronger visibility extending into 2027. Investors may view this as evidence of a longer-term growth cycle, although near-term margin pressure remains. MKSI Q2 Earnings Call Highlights AI-Driven Capacity Ramp
• Positive Sentiment: Analysts raised targets: Needham lifted its target from $360 to $390 and assigned a “Buy” rating. Wells Fargo raised its target from $300 to $325, while maintaining an “Equal Weight” rating. The revisions reinforce improving fundamentals but also show differing levels of analyst conviction.
• Neutral Sentiment: Brokerages collectively maintain a “Moderate Buy” recommendation, and the stock’s median recent analyst target is reported at $382.50.
• Negative Sentiment: Insider selling is a risk signal: Data compiled by Quiver Quantitative shows 40 insider sales and no insider purchases over the past six months. This may temper enthusiasm, although the transactions do not necessarily indicate a change in the company’s outlook.

MKS Company Profile

MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source